Fig. 4. IL-4/IL-13 expression is reduced in Stat6-/- mammary
glands and these cytokines are required for mammary gland development.
(A) Quantitative real-time-PCR was performed using specific primers for
Il4, Il13, Il5, Il12a and Gata3 on wild-type (WT) and
Stat6-/- glands at day 5 and 15 of gestation. Error bar
represents s.d. of three samples and is representative of at least two
experiments. (B-D) Whole mounts (left panels) and H&E-stained
sections (right panels) of inguinal mammary glands from wild-type (strain
matched) and IL-4-/-/IL-13-/- mice at day 5
(B), 10 (C) and 15 (D) of gestation. (E) The number of alveoli was
scored in H&E images from wild-type and
IL-4-/-/IL-13-/- mice at 40x
magnification and the area of the fat pad was measured using ImageJ software.
The number of alveoli/mm2 was calculated and the percentage
relative to wild-type was plotted. (F) Immunoblots for phosphorylated
(p)Stat6 and Stat6 were performed on wild-type and
IL-4-/-/13-/- mice at day 5 of gestation. The
density of the bands was quantified using ImageJ software and the ratio of
pStat6 to Stat6 plotted on a histogram.